Organization About
BIOQUAL, Inc. (BIOQUAL) was established in 1981 to perform contract research services focused on in vivo models of human diseases. Our models span a wide range of prevalent infectious diseases including (among others) COVID-19, influenza, RSV, HIV, Zika, Dengue, Malaria, MRSA and Mpox. BIOQUAL specializes in delivering individually tailored models for current and emerging diseases. These services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. In addition to infectious diseases, our model services now include syngeneic mouse tumor allograft and select human cell line derived xenograft (CDX) models. Our laboratories and vivarium are available for level 3 biocontainment, including studies of Select Agents. Service offerings are focused on meeting client needs regardless of animal model or specific disease type and delivery of downstream expertise throughout the process.
